The IC-D score for predicting prophylactic cardioverter-defibrillator implantation following acute myocardial

Nicolas Clementy1, Reda Bensaid1, Jérémie Bouteau1

  • 1Cardiology Department, Trousseau Hospital, University of Tours, Tours, France.

Insights

Predictors of poor left ventricular recovery after myocardial infarction (MI) include severely reduced ejection fraction and high cardiac enzyme levels. These factors indicate the need for cardioverter-defibrillator (ICD) implantation.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Biomarkers

Background:

  • Reduced left ventricular ejection fraction (LVEF) after myocardial infarction (MI) may necessitate cardioverter-defibrillator (ICD) implantation.
  • Identifying predictors of persistent LV dysfunction post-MI is crucial for patient management.

Purpose of the Study:

  • To identify predictors of significant left ventricular (LV) remodeling post-MI.
  • To develop a predictive score for persistent LVEF reduction.

Main Methods:

  • Retrospective analysis of 150 MI patients with LVEF ≤35% at discharge.
  • Logistic regression to identify predictors of non-recovery of LVEF at 6 weeks.
  • External validation of a predictive score (IC-D score).

Main Results:

  • An LVEF ≤25% at discharge and a peak CPK >4600 UI/L independently predicted non-recovery of LVEF.
  • The IC-D score demonstrated good predictive performance (AUC 0.83 in the study population, 0.73 in validation cohort).

Conclusions:

  • Severely reduced LVEF and elevated myocardial necrosis biomarkers predict unfavorable LV remodeling post-MI.
  • These factors suggest the need for prophylactic ICD implantation.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
197
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
104
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
125
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
121
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
74
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
75